Meridien Research

Tampa, Florida 34203

0 studies enrolling now · 73 studies all time

What they study most

Acne Vulgaris, Acute Migraine, Adult Attention Deficit Hyperactivity Disorder, Age-Related Memory Disorders, Alzheimer Disease, Alzheimer's Disease, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorders, Attention-Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), Autoimmune Diseases of the Nervous System

Studies at this site

A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression — Completed
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) — Completed
Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
Acute Treatment Trial in Adult Subjects With Migraines — Completed
Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy — Completed
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine — Completed
Open Label Safety Study in Acute Treatment of Migraine — Completed
Safety and Efficacy in Adult Subjects With Acute Migraines — Completed
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease — Paused
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment — Completed
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS — Withdrawn before enrolling
Mylan Insulin Aspart Study — Completed
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators — Withdrawn before enrolling
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
RN624 For Pain Of Post-Herpetic Neuralgia — Completed
Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) — Completed
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy — Stopped early
Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia — Completed
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain — Completed
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients — Completed
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression — Completed
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
Tricaprilin in Mild to Moderate Alzheimer's Disease — Completed
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: — Completed
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus — Completed
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis — Completed
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis — Completed
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris — Completed
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation — Completed
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) — Completed
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use — Completed
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension — Completed
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine — Completed
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients — Completed